Pentobarbital

Verify with FDA CVM →

39 adverse event reports submitted to the FDA

Important: Adverse event reports do not establish that a drug caused or contributed to the event. Consult your veterinarian before making treatment decisions.
39
Total Reports
26
Deaths Reported
6670.0%
Death Rate

Active Ingredients

Pentobarbital

Administration Routes

IntravenousUnknownOralOtherOphthalmicIntracardiac

Species Affected

Dog 16
Unknown 9
Horse 6
Cat 4
Other 2
Human 1
Mouse 1

Most Affected Breeds

Unknown 16
Dog (unknown) 7
Horse (unknown) 3
Cat (unknown) 3
Retriever - Labrador 2
Quarter Horse 2
Mixed (Horse) 1
Mixed (Dog) 1
Mixed (Cat) 1
Akita 1

Most Reported Reactions

INEFFECTIVE, EUTHANASIA 15
Uncoded sign 8
Vials, Leaking 7
Lack of efficacy - NOS 7
Seal, Abnormal 4
Accidental exposure 2
Potency, Low 2
Agitation 2
Injection site pain 2
Injection site irritation 2
Vascular disorder NOS (see also endocarditis) 2
Necropsy performed 2

Outcome Breakdown

Euthanized
16 (61.5%)
Died
10 (38.5%)

Data Summary

Metric Value
Total adverse event reports 39
Reports involving death 26
Case-fatality rate (reported events) 6670.0%
Distinct species in reports 7
Distinct breeds in reports 12
Distinct reactions reported 20
Active ingredients on file 1

Source: FDA Center for Veterinary Medicine — Adverse Event Reporting (CVM AER). Counts reflect voluntary reports only.

Pentobarbital Adverse Event Insights

The FDA Center for Veterinary Medicine database currently holds 39 adverse event reports referencing Pentobarbital, including 26 reports in which the animal died — a 6670.0% case-fatality figure among reported events only, not a population-level mortality rate. Active ingredient on file: Pentobarbital. Reported administration routes include Intravenous, Unknown, Oral, Other. These numbers reflect voluntary submissions from pet owners, veterinarians, and manufacturers and therefore under-represent mild events and over-represent severe ones — a pattern the FDA has documented repeatedly for pharmacovigilance datasets.

The species most frequently named in Pentobarbital reports are Dog (16 reports), Unknown (9 reports), Horse (6 reports), with Dog accounting for the largest share. Within those species, Unknown (16), Dog (unknown) (7), Horse (unknown) (3) appear most often — though breed popularity and ownership density shape these counts as much as any drug-specific sensitivity. This distribution matters because the same active ingredient can behave very differently across body sizes, ages, and species physiology.

The most commonly reported clinical signs associated with Pentobarbital are INEFFECTIVE, EUTHANASIA (15), Uncoded sign (8), Vials, Leaking (7), Lack of efficacy - NOS (7). Of the 26 reports with a coded outcome, Euthanized is the leading category at 61.5%. Because FDA adverse event data describes correlation rather than causation, these figures are best used to frame informed questions with a veterinarian and to compare reporting patterns across related products — not as a standalone safety verdict on Pentobarbital.

Source: FDA Center for Veterinary Medicine — Adverse Event Reports FDA Center for Veterinary Medicine — Adverse Event Reports Data reflects voluntary submissions and may not represent actual incidence rates

Related

Data sourced from official AKC, AVMA, ACVO, and breed-club veterinary references. See our methodology for details. Retrieved and formatted by PlainBreed Editorial